-transparent.png){kind=logo}
After initial promotion of copper excretion with D-penicillamine, the effect of oral zinc sulphate (3 X 150 mg/day, loading dose; 3 X 100 mg/day, maintenance dose) in two children with clinically stable Wilson's disease was evaluated after completion of three years' treatment. The course, judged by clinical, biochemical, and histological parameters was satisfactory in both. The urinary copper concentration reverted to less than 1.26 mumol/24 hours; and the serum copper concentration decreased further during zinc sulphate treatment. In one child the rise in 24 hour urinary copper excretion observed after a challenge dose of D-penicillamine (+/- 20 mg/kg) remained constant throughout the period of observation while the liver copper content fell from 1460 micrograms/g dry weight to 890 micrograms/g dry weight. In the other patient, however, the liver copper content as well as the 24 hour urinary copper excretion increased after D-penicillamine challenge during the third year of treatment. We conclude that zinc sulphate is a low toxic and well tolerated alternative for D-penicillamine. The dosage depends, however, on individual factors not yet well understood, and we recommend restriction of its use to patients who do not tolerate D-penicillamine well. We suggest monitoring of treatment with yearly D-penicillamine challenge and a liver biopsy if liver function deteriorates.
M Van Caillie-Bertrand, and
H J Degenhart, and
H K Visser, and
M Sinaasappel, and
J Bouquet
January 1990,
Acta physiologica Hungarica,
M Van Caillie-Bertrand, and
H J Degenhart, and
H K Visser, and
M Sinaasappel, and
J Bouquet
September 1984,
British medical journal (Clinical research ed.),
M Van Caillie-Bertrand, and
H J Degenhart, and
H K Visser, and
M Sinaasappel, and
J Bouquet
August 1984,
British medical journal (Clinical research ed.),
M Van Caillie-Bertrand, and
H J Degenhart, and
H K Visser, and
M Sinaasappel, and
J Bouquet
January 1979,
European neurology,
M Van Caillie-Bertrand, and
H J Degenhart, and
H K Visser, and
M Sinaasappel, and
J Bouquet
May 1984,
Nutrition reviews,
M Van Caillie-Bertrand, and
H J Degenhart, and
H K Visser, and
M Sinaasappel, and
J Bouquet
September 1983,
Annals of internal medicine,
M Van Caillie-Bertrand, and
H J Degenhart, and
H K Visser, and
M Sinaasappel, and
J Bouquet
December 1978,
Lancet (London, England),
M Van Caillie-Bertrand, and
H J Degenhart, and
H K Visser, and
M Sinaasappel, and
J Bouquet
January 1989,
Pharmacological research,
M Van Caillie-Bertrand, and
H J Degenhart, and
H K Visser, and
M Sinaasappel, and
J Bouquet
October 1982,
Archives of neurology,
M Van Caillie-Bertrand, and
H J Degenhart, and
H K Visser, and
M Sinaasappel, and
J Bouquet
July 2013,
World journal of gastroenterology,
